Lv1
20 积分 2024-06-25 加入
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance
6个月前
已完结
Sequential targeting in multiple myeloma: talquetamab, a GPRC5D bispecific antibody, as a bridge to BCMA CAR-T therapy
6个月前
已完结
Towards personalized, tumour-specific, therapeutic vaccines for cancer
7个月前
已完结
皖公网安备34019202002308
